CCM
VCYT icon

Chiron Capital Management’s Veracyte VCYT Stock Holding History

Chiron Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71
Closed -$2K – 427
2020
Q3 		$2K Buy
+71
New +$2.26K ﹤0.01% 455

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chiron Capital Management's VCYT Position: Q4 2020 in Review

Chiron Capital Management sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 71 shares — an estimated $2K sold.

Chiron Capital Management first reported a position in VCYT in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

  • Chiron Capital Management reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
  • Chiron Capital Management sold 71 Veracyte shares in Q4 2020, an estimated $2K.
  • Chiron Capital Management first reported a position in Veracyte in Q3 2020 and held it in 1 quarter.
  • Chiron Capital Management's Veracyte position peaked at $2K in Q3 2020.
  • 222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.